Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.51 |
| ▸ | BTK | Q06187 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 2/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1296128 | 0.99 | EPHX2 (0.50) | EPHX2BTKNAAAEPHX1TSHR | |
| SCHEMBL1297443 | 0.99 | EPHX2 (0.50) | EPHX2BTKNAAAEPHX1TSHR | |
| SCHEMBL1296768 | 0.99 | EPHX2 (0.50) | EPHX2BTKNAAAEPHX1TSHR | |
| SCHEMBL1296777 | 0.99 | EPHX2 (0.50) | EPHX2BTKNAAAEPHX1TSHR | |
| SCHEMBL1296867 | 0.99 | EPHX2 (0.50) | EPHX2BTKNAAAEPHX1TSHR | |
| SCHEMBL27646548 | 0.99 | EPHX2 (0.50) | EPHX2BTKNAAAEPHX1TSHR | |
| SCHEMBL1297416 | 0.99 | EPHX2 (0.50) | EPHX2BTKNAAAEPHX1TSHR | |
| SCHEMBL1297470 | 0.96 | EPHX2 (0.46) | EPHX2BTKTSHRMEN1ALDH1A1 | |
| SCHEMBL14422649 | 0.90 | NAAA (0.43) | EPHX2NAAAEPHX1TSHRALDH1A1 | |
| SCHEMBL1296951 | 0.90 | BTK (0.40) | EPHX2BTKTSHRMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8889748-B2 | Process for producing expandable styrene polymer compositions | BASF SE (DE) | 2014-11-18 | — | — | US | disclosed |
| US-8535436-B2 | Use of cyclohexane polycarboxylic acid derivatives for removing dust from chemical construction products | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-09-17 | — | — | US | disclosed |
| US-8454744-B2 | Use of polyols and cyclohexane polycarboxylic acid derivatives for the removal of dust from chemical construction products | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-20120138206-A1 | ADHESIVES AND SEALANTS CONTAINING CYCLOHEXANE POLYCARBOXYLIC ACID DERIVATIVES | BASF SE (DE) | 2012-06-07 | — | — | US | disclosed |
| US-20110291040-A1 | PROCESS FOR PRODUCING EXPANDABLE STYRENE POLYMER COMPOSITIONS | BASF SE (DE) | 2011-12-01 | — | — | US | disclosed |
| US-20110265693-A1 | Use Of Polyols And Cyclohexane Polycarboxylic Acid Derivatives For The Removal Of Dust From Chemical Construction Products | Construction Research & Tecnology GMBH (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20110232825-A1 | CYCLOHEXANE POLYCARBOXYLIC ACID DERIVATIVES AS PLASTICIZERS FOR ADHESIVES AND SEALANTS | BASF SE (DE) | 2011-09-29 | — | — | US | disclosed |
| US-20110209644-A1 | Use of Cyclohexane Polycarboxylic Acid Derivatives For Removing Dust From Chemical Construction Products | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2011-09-01 | — | — | US | disclosed |
| US-7337913-B2 | Single piece closure device made of PVC | BASF AKTIENGESELLSCHAFT (DE) | 2008-03-04 | — | — | US | disclosed |
| CN-1784203-A | Cosmetic composition containing cyclohexane polycarboxylic acid derivative | BASF AG (DE) | 2006-06-07 | — | — | CN | disclosed |
| US-20050106405-A1 | Single piece closure device made of pvc | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110209644-A1 | Use of Cyclohexane Polycarboxylic Acid Derivatives For Removing Dust From Chemical Construction Products | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HPD, HCAR2 | EPHX2 238/4885BTK 4869/4885NAAA 1278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.